Drug Patents owned by Cubist Pharms
1. List of Entereg drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8946262 | CUBIST PHARMS | Methods of preventing and treating gastrointestinal dysfunction |
Feb, 2030
(6 years from now) | |
Drugs and Companies using ALVIMOPAN ingredient
Market Authorisation Date: 20 May, 2008
Treatment: A method to accelerate the time to gastrointestinal recovery by administering about 12 mg of alvimopan to the patient from about 30 to 60 minutes prior to surgery
Dosage: CAPSULE;ORAL
How can I launch a generic of ENTEREG before it's patent expiration?
More Information on Dosage
ENTEREG family patents
4
United States
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic